De Felice Francesca, Vai Alessandro, Camarda Anna Maria, Iacovelli Nicola Alessandro, Orlandi Ester
Radiation Oncology, Policlinico Umberto I, Department of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, Viale Regina Elena 326, 00161 Rome, Italy.
Radiation Oncology, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Strada Campeggi 53, 27100 Pavia, Italy.
J Clin Med. 2022 Jun 9;11(12):3297. doi: 10.3390/jcm11123297.
Undifferentiated carcinoma of the nasopharynx (NPC) is a rare disease, which usually occurs in the Asian population. Due to its anatomic location, it is characterised by rich lymph node drainage and has a high incidence of cervical node metastasis. However, cervical nodal metastasis commonly involves retropharyngeal nodes and level II nodes, followed by level III nodes. In recent years, innovations in terms of systemic treatments and radiotherapy techniques have improved oncological outcome and treatment-related toxicities. Therefore, there is a growing interest in de-intensification strategies of reducing volumes and treatment-related side effects, especially in patients with NPC with N0-N1-stage disease. Proton therapy could represent a valid alternative to Intensity Modulated Radiotherapy (IMRT) in the management of NPC in this setting. With this Commentary, we aim to explore the feasibility of Intensity Modulated Proton Therapy (IMPT) in upper-neck irradiation of NPC N1-stage disease. We selected an NPC patient with N1 disease and compared the original IMRT plan with the IMPT plan in terms of dosimetric parameters. IMPT offers a minimal dosimetric advantage over IMRT in the bilateral lower-neck sparing. Clinical trials are needed to evaluate the significance of these proposed suggestions and their applicability in non-endemic areas.
未分化鼻咽癌(NPC)是一种罕见疾病,通常发生在亚洲人群中。由于其解剖位置,其特点是淋巴结引流丰富,颈部淋巴结转移发生率高。然而,颈部淋巴结转移通常累及咽后淋巴结和Ⅱ区淋巴结,其次是Ⅲ区淋巴结。近年来,全身治疗和放疗技术的创新改善了肿瘤治疗效果和治疗相关毒性。因此,人们越来越关注减少放疗体积和治疗相关副作用的降强度策略,尤其是对于N0-N1期疾病的鼻咽癌患者。在这种情况下,质子治疗可能是调强放射治疗(IMRT)治疗鼻咽癌的有效替代方案。通过本评论,我们旨在探讨调强质子治疗(IMPT)在鼻咽癌N1期疾病上颈部照射中的可行性。我们选择了一名N1期疾病的鼻咽癌患者,并在剂量学参数方面将原始IMRT计划与IMPT计划进行了比较。在双侧下颈部 sparing方面,IMPT相对于IMRT具有最小的剂量学优势。需要进行临床试验来评估这些建议的意义及其在非流行地区的适用性。